UNSPSC 51162321: Acetaminophen/phenylpropanolamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162321 Acetaminophen/phenylpropanolamine is a Commodity code that in recent state and local procurement shows limited direct application to the code's nominal scope; the two recent opportunities tagged to this code reflect pharmaceutical and over-the-counter product procurement broadly, rather than acetaminophen or phenylpropanolamine specifically. Seminole County, Florida is procuring naloxone and safe drug deactivation systems through an IFB, while the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) is establishing multiple contracts for generic multi-source pharmaceuticals and OTC products through an RFP—neither of which targets the specific active pharmaceutical ingredients this code nominally describes. State and local buyers accessing this code appear to use it as a tag for pharmaceutical procurement across multiple active ingredients and product categories rather than as a narrow commodity classifier. Issuing bodies include county health departments and state cooperative purchasing alliances that aggregate procurement across multiple member jurisdictions.

The geographic spread is limited in recent activity, with Seminole County, Florida and the Minnesota Multistate Cooperative Purchasing Alliance (which includes Oregon and other participating states) representing the visible recent solicitations. Seminole County's IFB (IFB60459723LAS) seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, due July 26, 2023, with a two-year initial term and one-year renewal option; bidders must provide unit costs, maintain workers' compensation and general liability insurance, comply with E-Verify requirements, and include all shipping and delivery costs in proposals. MMCAP's RFP (S1070000015802) for generic multi-source pharmaceuticals and OTC products, due March 26, 2026, requires manufacturers to supply products through three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, and Morris & Dickson), certify cGMP and Drug Supply Chain Security Act compliance, maintain pricing flexibility across multiple formats, and carry commercial general liability of $5 million per occurrence; the contract is effective July 1, 2026, for two years. The mismatch between the code's nominal scope and the actual solicitations suggests this code sees inconsistent or mislabeled application in state and local procurement systems.